Fundacion Para La Investigacion Medica Aplicada (FIMA), a not-for-profit foundation part of the Center for Applied Medical Research (CIMA) of the University of Navarra based in Pamplona, Spain, and Vivet Therapeutics have formed a close collaboration involving the exclusive license to Vivet Therapeutics of FIMA’s novel proprietary AAV vector gene therapy technology to treat some liver diseases. Vivet Therapeutics and FIMA also work together on several projects to further develop this technology and perform cutting-edge research in several key liver disease areas, such as Wilson disease.